Home
>
National Drug Code (NDC)
>
Provenge
Provenge - 30237-8900-6 - (sipuelucel-T)
Drug Information of Provenge
| Product NDC: | 30237-8900 |
| Proprietary Name: | Provenge |
| Non Proprietary Name: | sipuelucel-T |
| Active Ingredient(s): | 50000000 1/1 & nbsp; sipuelucel-T |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Provenge
| Product NDC: | 30237-8900 |
| Labeler Name: | Dendreon Corporation |
| Product Type: | CELLULAR THERAPY |
| FDA Application Number: | BLA125197 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100429 |
Package Information of Provenge
| Package NDC: | 30237-8900-6 |
| Package Description: | 1 BAG in 1 CARTON (30237-8900-6) > 1 INJECTION in 1 BAG |
NDC Information of Provenge
| NDC Code | 30237-8900-6 |
| Proprietary Name | Provenge |
| Package Description | 1 BAG in 1 CARTON (30237-8900-6) > 1 INJECTION in 1 BAG |
| Product NDC | 30237-8900 |
| Product Type Name | CELLULAR THERAPY |
| Non Proprietary Name | sipuelucel-T |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100429 |
| Marketing Category Name | BLA |
| Labeler Name | Dendreon Corporation |
| Substance Name | SIPULEUCEL-T |
| Strength Number | 50000000 |
| Strength Unit | 1/1 |
| Pharmaceutical Classes | Autologous Cellular Immunotherapy [EPC],Cell-mediated Immunity [PE],Cells, Cultured, Autologous [Chemical/Ingredient],Peripheral Blood Mononuclear Cells [Chemical/Ingredient] |
